IDEXX Laboratories, Inc. vs Jumia Technologies AG - ADR — how do they compare? IDEXX Laboratories, Inc. trades at $563.81 (market cap $44.48B), while Jumia Technologies AG - ADR trades at $6.35 (market cap $783.99M). The key difference: IDEXX Laboratories, Inc. is far larger — about 56.7× Jumia Technologies AG - ADR's market cap. Which is the better fit depends on your goals.
| IDXX | JMIA | |
|---|---|---|
Market Cap | $44.48B | $783.99M |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $14.60 |
52-Week Low | $520.87 | $4.45 |
Enterprise Value | $45.38B | $731.09M |
Trailing returns across standard periods
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates most of its revenue from the West Africa segment.
Read more on JMIA →